相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms
Jana Hildebrandt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Photoactivated Osmium Arene Anticancer Complexes
Xuling Xue et al.
INORGANIC CHEMISTRY (2021)
Novel organo-osmium(ii) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth in Caenorhabditis elegans
Enrique Ortega et al.
INORGANIC CHEMISTRY FRONTIERS (2021)
Synthesis, structure and anti-cancer activity of osmium complexes bearing π-bound arene substituents and phosphane Co-Ligands: A review
Tomiris Nabiyeva et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action
Aleen Khoury et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes
Antonino Arenaza-Corona et al.
INORGANIC CHEMISTRY (2020)
Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells
Javier Espino et al.
SCIENTIFIC REPORTS (2020)
Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy
John A. Roque et al.
CHEMICAL SCIENCE (2020)
Novel tetranuclear PdII and PtII anticancer complexes derived from pyrene thiosemicarbazones
Carolina G. Oliveira et al.
DALTON TRANSACTIONS (2020)
A tri-metallic palladium complex with breast cancer stem cell potency
Arvin Eskandari et al.
DALTON TRANSACTIONS (2020)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny et al.
CHEMICAL REVIEWS (2019)
Intracellular Catalysis with Selected Metal Complexes and Metallic Nanoparticles: Advances toward the Development of Catalytic Metallodrugs
Joan Josep Soldevila-Barreda et al.
CHEMICAL REVIEWS (2019)
New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells
Francisco J. Ballester et al.
CHEMICAL COMMUNICATIONS (2019)
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development
Samuel M. Meier-Menches et al.
CHEMICAL SOCIETY REVIEWS (2018)
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium
Chilaluck C. Konkankit et al.
DALTON TRANSACTIONS (2018)
The side effects of platinum-based chemotherapy drugs: a review for chemists
Rabbab Oun et al.
DALTON TRANSACTIONS (2018)
Anticancer metallodrugs: where is the next cisplatin?
Muhammad Hanif et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Functional Analyses of RUNX3 and CaMKIIN in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIIN and Dichotomous Roles for RUNX3 Transcript Variants
Karolin Heinze et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
Daniel Kritsch et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro
Kaushik Banerjee et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(II) polypyridyl complexes as anticancer drug candidates
Anna Notaro et al.
CHEMICAL SOCIETY REVIEWS (2017)
Cytotoxic platinum coordination compounds. DNA binding agents
Viktor Brabec et al.
COORDINATION CHEMISTRY REVIEWS (2017)
Platinum-based drugs: past, present and future
Shahana Dilruba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Comprehensive review on tumour active palladium compounds and structure-activity relationships
Md Nur Alam et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Cisplatin binding to proteins: A structural perspective
Luigi Messori et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Structure-antiproliferative activity studies on L-proline- and homoproline-4-N-pyrrolidine-3-thiosemicarbazone hybrids and their nickel(II), palladium(II) and copper(II) complexes
Aliona Dobrova et al.
DALTON TRANSACTIONS (2016)
Platinum(IV) anticancer prodrugs - hypotheses and facts
Dan Gibson
DALTON TRANSACTIONS (2016)
Platinum(II) O,S complexes as potential metallodrugs against Cisplatin resistance
Jana Hildebrandt et al.
DALTON TRANSACTIONS (2016)
Unusual mode of protein binding by a cytotoxic π-arene ruthenium(II) piano-stool compound containing an O,S-chelating ligand
Jana Hildebrandt et al.
DALTON TRANSACTIONS (2016)
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes
Lara Massai et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding
Carolin Muegge et al.
INORGANIC CHEMISTRY (2015)
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
Franco M. Muggia et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cationic Pd(II)/Pt(II) 5,5-diethylbarbiturate complexes with bis(2-pyridylmethyl)amine and terpyridine: Synthesis, structures,DNA/BSA interactions, intracellular distribution, cytotoxic activity and induction of apoptosis
Ceyda Icsel et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
Isolda Romero-Canelon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis, DNA/protein binding, molecular docking, DNA cleavage and in vitro anticancer activity of nickel(II) bis(thiosemicarbazone) complexes
Jebiti Haribabu et al.
RSC ADVANCES (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions
Carolin Mugge et al.
DALTON TRANSACTIONS (2014)
Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells
Mamoru Tanaka et al.
BMC CANCER (2013)
Monofunctional and Higher-Valent Platinum Anticancer Agents
Timothy C. Johnstone et al.
INORGANIC CHEMISTRY (2013)
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Isolda Romero-Canelon et al.
INORGANIC CHEMISTRY (2013)
Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity
Ana I. Matesanz et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
An Oxygen-Chelate Complex, Palladium Bis-acetylacetonate, Induces Apoptosis in H460 Cells via Endoplasmic Reticulum Stress Pathway Rather than Interacting with DNA
Yi Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
Ute Jungwirth et al.
MOLECULAR PHARMACOLOGY (2012)
A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells
Fabiana A. Serrano et al.
BMC CANCER (2011)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
Britta Stordal et al.
CANCER TREATMENT REVIEWS (2007)
Two closely related nickel complexes have different effects on DNA damage and cell viability
SS Matkar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Synthesis and analytical characterization of functionalized beta-hydroxydithiocinnamic acids and their esters. Complex chemistry towards nickel(II), palladium(II), and platin(II)
Karsten Schubert et al.
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE (2006)
Synthesis and analytical characterization of novel pyridyl-substituted 1,1 '-ethenedithiolato complexes
K Schubert et al.
HETEROATOM CHEMISTRY (2005)
Functionalized derivatives of beta-hydroxydithiocinnamic acids as ligands. Crystal structure of 4 '-Hydroxy-beta-hydroxydithiocinnamic acid methyl ester
K Schubert et al.
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE (2003)
分享论文
